Literature DB >> 33668738

Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy.

Martina De Siena1, Lucrezia Laterza1, Maria Valeria Matteo1, Irene Mignini1, Tommaso Schepis1, Gianenrico Rizzatti1, Gianluca Ianiro1, Emanuele Rinninella2, Marco Cintoni3, Antonio Gasbarrini1.   

Abstract

Pregnancy is characterized by maternal adaptations that are necessary to create a welcoming and hospitable environment for the fetus. Studies have highlighted how the microbiota modulates several networks in humans through complex molecular interactions and how dysbiosis (defined as quantitative and qualitative alterations of the microbiota communities) is related to human pathologies including gynecological diseases. This review analyzed how maternal uterine, vaginal, and gut microbiomes could impact on fetus health during the gestational period. We evaluated the role of a dysbiotic microbiota in preterm birth, chorioamnionitis, gestational diabetes mellitus and pre-eclampsia. For many years it has been hypothesized that newborns were sterile organisms but in the past few years this paradigm has been questioned through the demonstration of the presence of microbes in the placenta and meconium. In the future, we should go deeper into the concept of in utero colonization to better understand the role of microbiota through the phases of pregnancy. Numerous studies in the literature have already showed interesting results regarding the role of microbiota in pregnancy. This evidence gives us the hope that microbiota modulation could be a novel strategy to reduce the morbidity and mortality related to pregnancy complications in the future.

Entities:  

Keywords:  endometrial microbiota; gestational diabetes mellitus; microbiota; placental microbiota; pre-eclampsia; pregnancy; preterm birth; vaginal microbiota

Year:  2021        PMID: 33668738      PMCID: PMC7996258          DOI: 10.3390/microorganisms9030473

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  124 in total

1.  Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses.

Authors:  Victoria L Meah; John R Cockcroft; Karianne Backx; Rob Shave; Eric J Stöhr
Journal:  Heart       Date:  2016-01-21       Impact factor: 5.994

2.  Cardiovascular function before, during, and after the first and subsequent pregnancies.

Authors:  J F Clapp; E Capeless
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

Review 3.  Ecological dynamics of the vaginal microbiome in relation to health and disease.

Authors:  Shirley Greenbaum; Gili Greenbaum; Jacob Moran-Gilad; Adi Y Weintraub
Journal:  Am J Obstet Gynecol       Date:  2018-11-14       Impact factor: 8.661

Review 4.  Immunology of the maternal-fetal interface.

Authors:  Adrian Erlebacher
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

Review 5.  Involvement of galectin-1 in reproduction: past, present and future.

Authors:  Gabriela Barrientos; Nancy Freitag; Irene Tirado-González; Laura Unverdorben; Udo Jeschke; Victor L J L Thijssen; Sandra M Blois
Journal:  Hum Reprod Update       Date:  2013-09-27       Impact factor: 15.610

6.  Ultrastructural studies of implantation sites from mice deficient in uterine natural killer cells.

Authors:  J D Greenwood; K Minhas; J P di Santo; M Makita; Y Kiso; B A Croy
Journal:  Placenta       Date:  2000-09       Impact factor: 3.481

7.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

Review 8.  Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis.

Authors:  Muriel Aldunate; Daniela Srbinovski; Anna C Hearps; Catherine F Latham; Paul A Ramsland; Raffi Gugasyan; Richard A Cone; Gilda Tachedjian
Journal:  Front Physiol       Date:  2015-06-02       Impact factor: 4.566

9.  Abnormal pregnancy outcomes in mice using an induced periodontitis model and the haematogenous migration of Fusobacterium nucleatum sub-species to the murine placenta.

Authors:  Sara Stockham; Justine E Stamford; Claire T Roberts; Tracy R Fitzsimmons; Ceilidh Marchant; P Mark Bartold; Peter S Zilm
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

10.  Lactobacillus iners Is Associated with Vaginal Dysbiosis in Healthy Pregnant Women: A Preliminary Study.

Authors:  Nengneng Zheng; Renyong Guo; Yinyu Yao; Meiyuan Jin; Yiwen Cheng; Zongxin Ling
Journal:  Biomed Res Int       Date:  2019-10-23       Impact factor: 3.411

View more
  4 in total

1.  Meconium Microbiome of Very Preterm Infants across Germany.

Authors:  Jonas Klopp; Pamela Ferretti; Claudius U Meyer; Katja Hilbert; Annette Haiß; Janina Marißen; Philipp Henneke; Hannes Hudalla; Sabine Pirr; Dorothee Viemann; Michael Zemlin; Sofia Kirke Forslund; Christoph Härtel; Peer Bork; Stephan Gehring; Thea Van Rossum
Journal:  mSphere       Date:  2022-01-12       Impact factor: 4.389

2.  Vaginal microbiome as a tool for prediction of chorioamnionitis in preterm labor: a pilot study.

Authors:  Daichi Urushiyama; Eriko Ohnishi; Wataru Suda; Masamitsu Kurakazu; Chihiro Kiyoshima; Toyofumi Hirakawa; Kohei Miyata; Fusanori Yotsumoto; Kazuki Nabeshima; Takashi Setoue; Shinichiro Nagamitsu; Masahira Hattori; Kenichiro Hata; Shingo Miyamoto
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

Review 3.  Epigenetic Links between Microbiota and Gestational Diabetes.

Authors:  Olimpia Mora-Janiszewska; Anna Faryniak-Zuzak; Dorota Darmochwał-Kolarz
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

4.  Association Between Vaginal Gardnerella and Tubal Pregnancy in Women With Symptomatic Early Pregnancies in China: A Nested Case-Control Study.

Authors:  Yingxuan Zhang; Si Chen; Xiaofeng Chen; Huimin Zhang; Xuge Huang; Xiaomeng Xue; Yinan Guo; Xiaofeng Ruan; Xiaorong Liu; Gaopi Deng; Songping Luo; Jie Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-01-17       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.